Does deflazacort therapy offer any advantages over conventional corticosteroids in children with renal disease?
Clark
G
G
Department of Paediatrics, Guy's Hospital, London, UK.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*; D011282:Pregnenediones / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; C021988:deflazacort